GlassScriptPhysician profile
Stephen M Offutt
NPI 1700889102
$541.98
in general payments reported to CMS, 2019-2025
11 companies · $388 in 2025
The $388 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $97.00 · 2024: $57.03 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $541.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $176.52 | 2024-2025 | Nuzyra |
| Globus Medical, INC. | $67.38 | 2025 | Senza |
| Stryker Corporation | $59.55 | 2023 | Easyfuse |
| Kerecis Limited | $53.36 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Averitas Pharma INC. | $42.03 | 2023-2024 | Qutenza |
| Depuy Synthes Sales INC. | $36.25 | 2025 | Na |
| Boston Scientific Corporation | $30.67 | 2025 | Accolade Sr |
| Tactile Systems Technology INC | $29.22 | 2025 | Flexitouch Plus, Nimbl |
| Dynasplint Systems INC. | $19.10 | 2025 | Dynasplint |
| Medtronic, INC. | $14.09 | 2023 | Intellis Adaptivestim |
| Smith+Nephew, INC. | $13.81 | 2025 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Offutt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.